Delivery options for wet AMD gene therapy under investigation

In a Healio Video Perspective from Retina 2024, Dr. Lejla Vajzovic discusses advancements in gene therapy for wet age-related macular degeneration (AMD) at a conference in Hawaii. Several companies are currently conducting trials to evaluate different gene therapy delivery options for AMD, including subretinal, intravitreal, and suprachoroidal approaches. Dr. Vajzovic expresses excitement about the progress in gene therapy and hopes to see a product for wet AMD in the near future. She discloses her involvement in advising and conducting clinical trials for Regenxbio.

Source link

error: Content is protected !!